KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹154 Cr | ₹140 Cr | ₹114 Cr | ₹69 Cr | ₹53 Cr |
What is the latest Revenue of KILITCH DRUGS (INDIA) ?
Year | Revenue |
---|---|
Mar2024 | ₹154 Cr |
Mar2023 | ₹140 Cr |
Mar2022 | ₹114 Cr |
Mar2021 | ₹69 Cr |
Mar2020 | ₹53 Cr |
How is Revenue of KILITCH DRUGS (INDIA) Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹154 Cr | 10.58 | |
Mar2023 | ₹140 Cr | 22.20 | |
Mar2022 | ₹114 Cr | 66.71 | |
Mar2021 | ₹69 Cr | 28.51 | |
Mar2020 | ₹53 Cr | - |
Compare Revenue of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹747.2 Cr | 9.1% | 3.2% | 27.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 9.1% |
3.2% |
27.5% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses